The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume 9, Issue 10, Pages 579-590
Publisher
Springer Nature
Online
2012-09-04
DOI
10.1038/nrclinonc.2012.150
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of FLT3 Internal Tandem Duplication on the Outcome of Related and Unrelated Hematopoietic Transplantation for Adult Acute Myeloid Leukemia in First Remission: A Retrospective Analysis
- (2012) Salut Brunet et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories
- (2012) Jan J. Cornelissen et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants?
- (2011) Eric J. Feldman BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Donor Characteristics Affecting Graft Failure, Graft-versus-Host Disease, and Survival after Unrelated Donor Transplantation with Reduced-Intensity Conditioning for Hematologic Malignancies
- (2011) Jakob R. Passweg et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Comparison of Reduced-Intensity Hematopoietic Cell Transplantation with Chemotherapy in Patients Age 60-70 Years with Acute Myelogenous Leukemia in First Remission
- (2011) Sherif S. Farag et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies
- (2011) S. Kayser et al. BLOOD
- Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation
- (2011) M. Fang et al. BLOOD
- Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers
- (2011) V. Rockova et al. BLOOD
- Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
- (2011) E. Vellenga et al. BLOOD
- Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria
- (2011) M. E. D. Flowers et al. BLOOD
- Twenty-five years of peripheral blood stem cell transplantation
- (2011) M. Korbling et al. BLOOD
- Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS
- (2011) S M Luger et al. BONE MARROW TRANSPLANTATION
- Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantation
- (2011) S W Bokhari et al. BONE MARROW TRANSPLANTATION
- The EBMT risk score
- (2011) A Gratwohl BONE MARROW TRANSPLANTATION
- Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia
- (2011) Gunnar Juliusson et al. CANCER
- Treatment of chronic graft-versus-host disease in 2011
- (2011) Yoshihiro Inamoto et al. CURRENT OPINION IN HEMATOLOGY
- Reduced intensity versus myeloablative allogeneic stem cell transplantation for the treatment of acute myeloid leukemia, myelodysplastic syndrome and acute lymphoid leukemia
- (2011) Mitchell E Horwitz CURRENT OPINION IN ONCOLOGY
- Allogeneic transplantation as post-remission therapy for cytogenetically high-risk acute myeloid leukemia: landmark analysis from a single prospective multicenter trial
- (2011) M. Stelljes et al. HAEMATOLOGICA
- Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation
- (2011) Alois Gratwohl et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Genetics of Adult Acute Myeloid Leukemia: Prognostic and Therapeutic Implications
- (2011) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?
- (2011) John T. Horan et al. JOURNAL OF CLINICAL ONCOLOGY
- Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group
- (2011) Jan Krönke et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
- (2011) Roland B. Walter et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-Term Survival and Late Deaths After Allogeneic Hematopoietic Cell Transplantation
- (2011) John R. Wingard et al. JOURNAL OF CLINICAL ONCOLOGY
- Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial
- (2011) Markus Pfirrmann et al. LANCET ONCOLOGY
- Predictive impact of allele-matching and EBMT risk score for outcome after T-cell depleted unrelated donor transplantation in poor-risk acute leukemia and myelodysplasia
- (2011) T Lodewyck et al. LEUKEMIA
- Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy in Elderly Patients with Non-M3 Acute Myelogenous Leukemia in First Complete Remission
- (2010) Saiko Kurosawa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities
- (2010) Hesham Eissa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
- (2010) V. Gupta et al. BLOOD
- A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission
- (2010) S. Kurosawa et al. BLOOD
- The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML
- (2010) S. Kayser et al. BLOOD
- Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
- (2010) E. Taskesen et al. BLOOD
- Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns
- (2010) V. Gupta et al. BLOOD
- Independent prognostic variables in acute myeloid leukaemia
- (2010) Matthew L. Smith et al. BLOOD REVIEWS
- Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome
- (2010) Marcos de Lima et al. CANCER
- Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation
- (2010) John A Hansen et al. CURRENT OPINION IN HEMATOLOGY
- Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies
- (2010) Didier Blaise et al. EXPERIMENTAL HEMATOLOGY
- Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse
- (2010) S. Kurosawa et al. HAEMATOLOGICA
- HighEVI1Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities
- (2010) Stefan Gröschel et al. JOURNAL OF CLINICAL ONCOLOGY
- IDH1andIDH2Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2010) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- IDH1 and IDH2 Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia With NPM1 Mutation Without FLT3 Internal Tandem Duplication
- (2010) Peter Paschka et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Significance ofCEBPAMutations in a Large Cohort of Younger Adult Patients With Acute Myeloid Leukemia: Impact of DoubleCEBPAMutations and the Interaction WithFLT3andNPM1Mutations
- (2010) Claire L. Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Minimal Residual Disease inCBFB-MYH11–Positive Acute Myeloid Leukemia
- (2010) Andrea Corbacioglu et al. JOURNAL OF CLINICAL ONCOLOGY
- Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
- (2010) Michel Duval et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A
- (2010) Richard F. Schlenk et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of Patients With Acute Myeloblastic Leukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial
- (2010) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: long-term follow-up
- (2010) A Shimoni et al. LEUKEMIA
- Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study
- (2010) K S Baker et al. LEUKEMIA
- Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
- (2010) Ted A. Gooley et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNMT3AMutations in Acute Myeloid Leukemia
- (2010) Timothy J. Ley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genomic polymorphisms of the innate immune system and allogeneic stem cell transplantation
- (2010) Beatriz Martín-Antonio et al. Expert Review of Hematology
- Quantifying the Survival Benefit for Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed Acute Myelogenous Leukemia
- (2009) Paul M. Armistead et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) in Single and Multiple Institutions: Limitations and Inferences
- (2009) Mohamed L. Sorror et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Busulfan in Hematopoietic Stem Cell Transplantation
- (2009) Stefan O. Ciurea et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Comparison of Two Pretransplant Predictive Models and a Flexible HCT-CI Using Different Cut off Points to Determine Low-, Intermediate-, and High-Risk Groups: The Flexible HCT-CI Is the Best Predictor of NRM and OS in a Population of Patients Undergoing allo-RIC
- (2009) Pere Barba et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Minimal residual disease levels assessed by NPM1 mutation-specific RQ-PCR provide important prognostic information in AML
- (2009) S. Schnittger et al. BLOOD
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome
- (2009) B. J. Wouters et al. BLOOD
- Risk score for outcome after allogeneic hematopoietic stem cell transplantation
- (2009) Alois Gratwohl et al. CANCER
- Molecular signatures in acute myeloid leukemia
- (2009) Krzysztof Mrózek et al. CURRENT OPINION IN HEMATOLOGY
- Reduced-intensity conditioning transplantation in myeloid malignancies
- (2009) Rainer Storb CURRENT OPINION IN ONCOLOGY
- Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission
- (2009) John Koreth et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reduced Intensity Conditioning Compared With Myeloablative Conditioning Using Unrelated Donor Transplants in Patients With Acute Myeloid Leukemia
- (2009) Olle Ringdén et al. JOURNAL OF CLINICAL ONCOLOGY
- Attempts to Optimize Induction and Consolidation Treatment in Acute Myeloid Leukemia: Results of the MRC AML12 Trial
- (2009) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute Myeloid Leukemia With Biallelic CEBPA Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome
- (2009) Annika Dufour et al. JOURNAL OF CLINICAL ONCOLOGY
- Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
- (2009) Jürgen Finke et al. LANCET ONCOLOGY
- Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission
- (2009) N Basara et al. LEUKEMIA
- What are the most important donor and recipient factors affecting the outcome of related and unrelated allogeneic transplantation?
- (2008) Claudio Anasetti BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
- (2008) S. Lugthart et al. BLOOD
- Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
- (2008) Mohamed Sorror et al. CANCER
- Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia
- (2008) D. Messerer et al. HAEMATOLOGICA
- Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group
- (2008) Johannes Schetelig et al. JOURNAL OF CLINICAL ONCOLOGY
- Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype
- (2008) Dimitri A. Breems et al. JOURNAL OF CLINICAL ONCOLOGY
- Toward Optimization of Postremission Therapy for Residual Disease–Positive Patients With Acute Myeloid Leukemia
- (2008) Luca Maurillo et al. JOURNAL OF CLINICAL ONCOLOGY
- Reduced intensity conditioning allogeneic stem cell transplantation for patients with acute myeloid leukemia: long term results of a ‘donor’ versus ‘no donor’ comparison
- (2008) M Mohty et al. LEUKEMIA
- Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
- (2008) Richard F. Schlenk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sustained Remissions of High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome After Reduced-Intensity Conditioning Allogeneic Hematopoietic Transplantation: Chronic Graft-Versus-Host Disease Is the Strongest Factor Improving Survival
- (2007) David Valcárcel et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started